Home › NDC Lookup › RxCUI directory › RxCUI 616449

Mycophenolic acid 360 MG Delayed Release Oral Tablet [Myfortic] — RxCUI 616449

RxNorm drug concept · Semantic branded drug
RxCUI 616449 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI616449
Official nameMycophenolic acid 360 MG Delayed Release Oral Tablet [Myfortic]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asMyfortic 360 MG Delayed Release Oral Tablet
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,586 prescriptions · 13 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Mycophenolic Acid: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The enteric coating on the tablet is designed to release the medicine in your intestine, not your stomach. Food doesn't block absorption entirely, but it delays and lowers the peak...
  • Why do I have to take this on an empty stomach? What happens if I take it with food?
  • Not on your own — and probably not without careful planning. Even though both medicines work the same way, mycophenolic acid delayed-release tablets and MMF are absorbed at differe...
  • Can I ever switch to the mycophenolate mofetil (MMF) pill instead?
📖 Read our full Mycophenolic Acid guide →

🕸️ Concept Web — How Mycophenolic acid 360 MG Delayed Release Oral Ta... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Mycophenolic acid 360 MG Delayed Release Oral Tablet [Myfortic] RxCUI 616449

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Mycophenolic acid 7145
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Myfortic 579570
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Mycophenolic acid Delayed Release Oral Tablet 485019
    • Mycophenolic acid Oral Product 1156390
    • Mycophenolic acid Pill 1156391
    • Mycophenolic acid Delayed Release Oral Tablet [Myfortic] 616448
    • Myfortic Oral Product 1184447
    • Myfortic Pill 1184448
    • Delayed Release Oral Tablet 10312
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Mycophenolic acid 360 MG [Myfortic] SBDC · 541585
  • Mycophenolic acid Delayed Release Oral Tablet [Myfortic] SBDF · 616448
  • Myfortic Oral Product SBDG · 1184447
  • Myfortic Pill SBDG · 1184448
  • Myfortic BN · 579570

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 616449 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00078-0385-66 120 TABLET, DELAYED RELEASE in 1 BOTTLE (0078-0385-66) Myfortic Novartis Pharmaceuticals Corporation 2004-02-27
00078-0386-66 120 TABLET, DELAYED RELEASE in 1 BOTTLE (0078-0386-66) Myfortic Novartis Pharmaceuticals Corporation 2004-02-27
Observed labelers: Novartis Pharmaceuticals Corporation (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J7518 Mycophenolic acid 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.